Antibodies & Hybridomas — page 1 of 6
Antibodies & Hybridomas
Page 1 of 6
| Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
|---|---|---|---|---|---|---|---|---|
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 001 | Rabbit | n/a | unconjugated | 100 µL | n/a |
 CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 001 | Rabbit | n/a | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 005 | Mouse | n/a | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 005 | Mouse | n/a | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | polyclonal | Rabbit | n/a | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | polyclonal | Rabbit | n/a | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Surface Glycoprotein | D005 | Chimeric | n/a | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Surface Glycoprotein | D005 | Chimeric | n/a | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | Fab2 fragment-His-tagged | 100 µg | n/a |
 ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | Fab2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Rabbit | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Cat | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Cat | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein | CV1 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | biotin conjugate | 50 µl|100 µl | n/a |
 ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | fluorescein (FITC) conjugate | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | peroxidase (HRP) conjugate | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Rabbit | n/a | unconjugated | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | affinity purified | 50 µg|100 µg | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | affinity purified | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | affinity purified | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Mouse | n/a | affinity purified | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | polyclonal | Rabbit | n/a | immunogen affinity purified | 30 µl|100 µl|1 ml | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Mouse | n/a | Protein A purified | 1 mg | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Mouse | n/a | Protein A purified | 1 mg | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human | n/a | unconjugated | 100 µl|1 ml | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | unconjugated | 50 µl|100 µl|200 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein | monoclonal | Human, Mouse | n/a | unconjugated | 50 µl|100 µl|200 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein scFv | monoclonal | E. coli | n/a | unconjugated | 100 µl|1 ml | n/a |
ABBEXA |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | Fab2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | Fab2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Rabbit | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Cat | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Human | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Mouse | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Spike Protein (RBD) | CV30 | Recombinant Cat | SARS Coronavirus 2 (SARS-Cov-2) | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 | 6F10 | Mouse | n/a | Purified from ascites by Protein G column, ? 95% based on SDS-PAGE | 50 µg | n/a |
 BIOVISION, INC. |
More Info |
| SARS-CoV-2 | polyclonal | Rabbit | n/a | ? 95% based on SDS-PAGE | 50 µg | n/a |
BIOVISION, INC. |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) S1 Protein | monoclonal | Rabbit | n/a | unconjugated | 50 µl|100 µl | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) S1 Protein | monoclonal | Human | n/a | unconjugated | 100 µl|1 ml | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Trimeric Spike 1 Protein | monoclonal | Mouse | n/a | Protein A purified | 1 mg | n/a |
ABBEXA |
More Info |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Trimeric Spike 1 Protein | monoclonal | Mouse | n/a | Protein A purified | 1 mg | n/a |
ABBEXA |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | Fab2 fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | Fab2 fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | Fab2 fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | Fab2 fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | Fab fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | Fab fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | Fab fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | Fab fragment-His-tagged | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Rabbit | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Rabbit | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Cat | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Cat | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | purified, Fc-silenced | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3009 (03-009) | Recombinant Cat | SARS-CoV; SARS-CoV2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Human | SARS-CoV; SARS-CoV2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Mouse | SARS-CoV; SARS-CoV2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| Covid-19 & SARS-CoV Nucleoprotein | CR3018 (03-018) | Recombinant Cat | SARS-CoV; SARS-CoV2 | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| SARS-CoV-2 Whole Spike Protein | polyclonal | Rabbit | sars coronavirus 2 spike | Protein A purified | 100 µg | n/a |
 ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
| SARS-CoV-2 Whole Spike Protein | polyclonal | Rabbit | sars coronavirus 2 spike | Protein A purified | 500 µg | n/a |
ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
| SARS-CoV-2 NP | 120 | Rabbit | n/a | Protein A purified | 50ul, 100ul | n/a |
 CREATIVE DIAGNOSTICS |
More Info |
| SARS-CoV-2 NP | polyclonal | Rabbit | n/a | unconjugated | n/a | n/a |
CREATIVE DIAGNOSTICS |
More Info |
| SARS-CoV-2 Nucleoprotein | 4B21 | Mouse | n/a | purified | 50ug | n/a |
CREATIVE DIAGNOSTICS |
More Info |
| SARS-CoV-2 Nucleoprotein | 7G21 | Mouse | n/a | purified | 50ug | n/a |
CREATIVE DIAGNOSTICS |
More Info |
| SARS-CoV-2 Nucleoprotein | CO10 | Human | n/a | Protein A purified | 100ug | n/a |
CREATIVE DIAGNOSTICS |
More Info |
| SARS-CoV-2 Nucleoprotein | CON12 | Humanized | n/a | unconjugated | 1 mL | n/a |
CREATIVE DIAGNOSTICS |
More Info |
| SARS-CoV-2 Nucleoprotein | TMOPO | Human | n/a | purified | 100ug | n/a |
CREATIVE DIAGNOSTICS |
More Info |